B6Brd;B6Dnk;B6N-Tyrc-Brd-Spns2tm1b(KOMP)Wtsi/WtsiH

Status

Available to order

EMMA IDEM:08571
International strain nameB6Brd;B6Dnk;B6N-Tyrc-Brd-Spns2tm1b(KOMP)Wtsi/WtsiH
Alternative nameEPD0090_5_B04
Strain typeTargeted Mutant Strains
Allele/Transgene symbolSpns2tm1b(KOMP)Wtsi
Gene/Transgene symbolSpns2
DisclaimerPlease note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
  1. We can not guarantee a null mutation for Knock-out first alleles (tm1a alleles, see http://www.mousephenotype.org/about-ikmc/targeting-strategies) as the critical exon has not been deleted.
  2. That the structure of the targeted mutation in the ES cells obtained from EUCOMM/KOMP to generate EUCOMM/KOMP mice is not verified by INFRAFRONTIER/EMMA. It is recommended that the recipient confirms the mutation structure.
  3. No check for determining the copy number of the targeting construct in ES cells obtained from EUCOMM/KOMP is done by INFRAFRONTIER/EMMA.
  4. The level of quality control before mice are released is to confirm the individual mouse genotype by short range PCR.

Information from provider

Provider Wellcome Trust Sanger Institute
Provider affiliationWellcome Trust Sanger Institute
Genetic informationThis mouse line originates from KOMP ES clone EPD0090_5_B04. For further details on the construction of this clone see the page at the IMPC portal. The critical exon(s) were flanked by loxP sites, and subsequent cre expression excised this critical sequence resulting in a knockout reporter allele using an X-linked CMV-Cre driver (EM:05414; C57BL/6N-Hprttm1(CMV-cre)Wtsi/WtsiOulu) for this purpose. Click here for more information on KOMP final vectors.
Phenotypic informationPotential phenotyping data in the IMPC portal
References
  • The role of sphingosine-1-phosphate transporter Spns2 in immune system function.;Nijnik Anastasia, Clare Simon, Hale Christine, Chen Jing, Raisen Claire, Mottram Lynda, Lucas Mark, Estabel Jeanne, Ryder Edward, Adissu Hibret, null null, Adams Niels C, Ramirez-Solis Ramiro, White Jacqueline K, Steel Karen P, Dougan Gordon, Hancock Robert E W, ;2012;Journal of immunology (Baltimore, Md. : 1950);189;102-11; 22664872
  • Spinster homolog 2 (spns2) deficiency causes early onset progressive hearing loss.;Chen Jing, Ingham Neil, Kelly John, Jadeja Shalini, Goulding David, Pass Johanna, Mahajan Vinit B, Tsang Stephen H, Nijnik Anastasia, Jackson Ian J, White Jacqueline K, Forge Andrew, Jagger Daniel, Steel Karen P, ;2014;PLoS genetics;10;e1004688; 25356849

Information from EMMA

Archiving centreMary Lyon Centre at MRC Harwell, Oxford, United Kingdom

Disease and phenotype information

IMPC phenotypes (allele matching)
  • decreased leukocyte cell number / IMPC
  • abnormal cornea morphology / IMPC
  • corneal opacity / IMPC
  • abnormal iris morphology / IMPC
  • trunk curl / IMPC
  • narrow eye opening / IMPC
  • corneal vascularization / IMPC
  • increased mean corpuscular hemoglobin / IMPC
  • absent pinna reflex / IMPC
  • decreased bone mineral content / IMPC
IMPC phenotypes (gene matching)
  • decreased bone mineral content / IMPC
  • absent pinna reflex / IMPC
  • corneal vascularization / IMPC
  • decreased circulating LDL cholesterol level / IMPC
  • decreased leukocyte cell number / IMPC
  • decreased circulating HDL cholesterol level / IMPC
  • corneal opacity / IMPC
  • decreased circulating glucose level / IMPC
  • increased circulating creatine kinase level / IMPC
  • decreased circulating serum albumin level / IMPC
  • narrow eye opening / IMPC
  • trunk curl / IMPC
  • abnormal cornea morphology / IMPC
  • abnormal eyelid aperture / IMPC
  • abnormal rib morphology / IMPC
  • abnormal iris morphology / IMPC
  • excessive tearing / IMPC
  • increased mean corpuscular hemoglobin / IMPC
  • inflammation / IMPC
  • abnormal eye pigmentation / IMPC
  • increased thermal nociceptive threshold / IMPC
  • abnormal eye size / IMPC
  • increased bone mineral density / IMPC
  • abnormal eye morphology / IMPC
  • developmental and structural abnormality / IMPC
  • increased circulating bilirubin level / IMPC
  • decreased circulating cholesterol level / IMPC
  • abnormal pupil morphology / IMPC
MGI phenotypes (allele matching)
  • decreased B cell number / MGI
  • increased CD4-positive, alpha beta T cell number / MGI
  • decreased CD4-positive, alpha beta T cell number / MGI
  • increased CD8-positive, alpha-beta T cell number / MGI
  • decreased CD8-positive, alpha-beta T cell number / MGI
MGI phenotypes (gene matching)
  • abnormal leukocyte cell number / MGI
  • increased monocyte cell number / MGI
  • decreased leukocyte cell number / MGI
  • decreased monocyte cell number / MGI
  • increased granulocyte number / MGI
  • abnormal thymus morphology / MGI
  • decreased thymocyte number / MGI
  • decreased body weight / MGI
  • microphthalmia / MGI
  • eyelids open at birth / MGI
  • cataract / MGI
  • small lens / MGI
  • abnormal cornea morphology / MGI
  • increased incidence of corneal inflammation / MGI
  • corneal opacity / MGI
  • abnormal pupil morphology / MGI
  • abnormal iris morphology / MGI
  • abnormal eye pigmentation / MGI
  • abnormal retina morphology / MGI
  • abnormal humoral immune response / MGI
  • decreased IgG level / MGI
  • increased susceptibility to bacterial infection / MGI
  • abnormal T cell physiology / MGI
  • abnormal B cell physiology / MGI
  • increased bone strength / MGI
  • abnormal iridocorneal angle / MGI
  • abnormal auditory brainstem response / MGI
  • abnormal behavior / MGI
  • decreased B-1 B cell number / MGI
  • decreased lymphocyte cell number / MGI
  • decreased B cell number / MGI
  • decreased T cell number / MGI
  • abnormal ciliary body morphology / MGI
  • eyelids fail to open / MGI
  • narrow eye opening / MGI
  • abnormal corneal stroma morphology / MGI
  • increased circulating bilirubin level / MGI
  • growth/size/body region phenotype / MGI
  • immune system phenotype / MGI
  • corneal vascularization / MGI
  • decreased circulating glucose level / MGI
  • absent pinna reflex / MGI
  • increased NK T cell number / MGI
  • increased NK cell number / MGI
  • increased CD4-positive, alpha beta T cell number / MGI
  • decreased CD4-positive, alpha beta T cell number / MGI
  • increased CD8-positive, alpha-beta T cell number / MGI
  • decreased CD8-positive, alpha-beta T cell number / MGI
  • increased single-positive T cell number / MGI
  • decreased single-positive T cell number / MGI
  • decreased follicular B cell number / MGI
  • decreased mature B cell number / MGI
  • decreased immature B cell number / MGI
  • decreased IgG1 level / MGI
  • decreased survivor rate / MGI
  • eye opacity / MGI
  • decreased transitional stage T1 B cell number / MGI
  • increased bone mineral content / MGI
  • symblepharon / MGI
  • abnormal mature B cell number / MGI
  • decreased sphingosine level / MGI

Literature references

  • The role of sphingosine-1-phosphate transporter Spns2 in immune system function.;Nijnik Anastasia, Clare Simon, Hale Christine, Chen Jing, Raisen Claire, Mottram Lynda, Lucas Mark, Estabel Jeanne, Ryder Edward, Adissu Hibret, null null, Adams Niels C, Ramirez-Solis Ramiro, White Jacqueline K, Steel Karen P, Dougan Gordon, Hancock Robert E W, ;2012;Journal of immunology (Baltimore, Md. : 1950);189;102-11; 22664872
  • Spinster homolog 2 (spns2) deficiency causes early onset progressive hearing loss.;Chen Jing, Ingham Neil, Kelly John, Jadeja Shalini, Goulding David, Pass Johanna, Mahajan Vinit B, Tsang Stephen H, Nijnik Anastasia, Jackson Ian J, White Jacqueline K, Forge Andrew, Jagger Daniel, Steel Karen P, ;2014;PLoS genetics;10;e1004688; 25356849

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*
  • Tissue - Types of tissue, service fee and delivery time available upon request

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
MTA will be issued after an order has been submitted.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).